Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
7.77
+0.18 (2.44%)
At close: Aug 13, 2025, 4:00 PM
7.70
-0.06 (-0.84%)
After-hours: Aug 13, 2025, 4:10 PM EDT
Inogen Market Cap
Inogen has a market cap or net worth of $208.21 million as of August 13, 2025. Its market cap has decreased by -8.68% in one year.
Market Cap
208.21M
Enterprise Value
104.82M
1-Year Change
-8.68%
Ranking
Category
Stock Price
$7.77
Market Cap Chart
Since February 14, 2014, Inogen's market cap has decreased from $274.90M to $208.21M, a decrease of -24.26%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 205.00M | -6.14% |
| Dec 31, 2024 | 218.40M | 70.63% |
| Dec 29, 2023 | 128.00M | -71.67% |
| Dec 30, 2022 | 451.80M | -41.52% |
| Dec 31, 2021 | 772.60M | -21.82% |
| Dec 31, 2020 | 988.20M | -34.26% |
| Dec 31, 2019 | 1.50B | -43.75% |
| Dec 31, 2018 | 2.67B | 7.54% |
| Dec 29, 2017 | 2.49B | 82.61% |
| Dec 30, 2016 | 1.36B | 72.72% |
| Dec 31, 2015 | 787.90M | 34.82% |
| Dec 31, 2014 | 584.40M | 112.59% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |